InvestorsHub Logo
Post# of 84352
Next 10
Followers 1
Posts 396
Boards Moderated 0
Alias Born 05/15/2019

Re: None

Friday, 07/05/2019 8:41:16 AM

Friday, July 05, 2019 8:41:16 AM

Post# of 84352
GOVX: IND filing for HIV cure..Market cap $360G= 560G total shares

GeoVax is in Stage 2B in partnership with the Feds and WHO for a PREVENT vax for HIV.

This is the second stage of HUMAN vax trials

They have a vax that is 100% effective. It also works on Ebola, Lassa, etc.

GOVX did a 1-500 R/S a few weeks ago and the stock price fell almost 90% from there.

Now GOVX has a market cap of $360Gs with over $120M in grant funding over the years and about as much private funding.

Various major world HIV/AIDs programs are committed to GOVX and their Vax Platform. No doubt that GOVX will continue to receive grants and funding.

Now GOVX, in conjunction with federal and global health partners is about to file the IND for its Platform.

Well worth doing the DD on this incredible company.


June21,2019:
"Regarding the upcoming HVTN 132 program, using GeoVax HIV preventive vaccine and a novel booster, we learned that the IND filing is expected to occur soon. This is encouraging and a welcomed acceleration from our previous target date."
Link:
https://www.linkedin.com/pulse/hvtn-132-program-advancing-david-a-dodd/?published=t

Website:
https://www.geovax.com/

NOTE: Any serious buying is good for 100% move at minimum. 560G total shares with about 200,000G free trading shares.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.